TokenPost topic
1 TokenPost story is tagged Merck. The newest appear first.
The Phase 3 INTerpath-001 findings are scheduled for presentation Oct. 24 in Madrid. The companies disclosed no numerical efficacy results in August.
Oct 15, 2026, 11:16 PM EDT ยท Investing